MedPath

ACT RIVASTIGMINE PATCH 5

ACT RIVASTIGMINE PATCH 5

Discontinued
DIN Number

02423529

Drug Class

Human

Market Date

N/A

Company
HC

actavis pharma company

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02423529
AIG Number0140521006
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N06DA03 RIVASTIGMINE
Product Specifications
Dosage FormPatch
Route of AdministrationTransdermal
AHFS Classification12:04.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

RIVASTIGMINEActive
Strength: 9 MG / 5 SQ CM
Monograph: RIVASTIGMINE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.